Home > Press > AlphaRx to Deliver Product Pipeline Updates at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
AlphaRx Inc. , a leading specialty pharmaceutical company with a unique focus on nanotechnology delivery platforms, will update the medical and investor communities on its product pipeline at the 9th Annual Healthcare Conference in New York, November 5-7, at the Plaza Hotel. Dr. David Milroy, the Director of Medical Research at AlphaRx, will provide detailed reports on the complete product pipeline including Clinical trial updates. Dr. Milroy will also present the latest information on Vansolin(TM), which targets nosocomial pneumonia and has a market value estimate of $3.6 billion. Dr. Milroy will present on Wednesday November 7th at 1:00 p.m. (Eastern Time) in the Kennedy II Room.
AlphaRx to Deliver Product Pipeline Updates at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
MARKHAM, ON, Canada | Posted on November 1st, 2007
A live webcast of AlphaRx's presentation can be accessed by logging onto
A replay of the presentation will be archived for 90 days after the conference, at the same site. For more information, please visit http://www.rodmanandrenshaw.com .
About AlphaRx Inc.
AlphaRx is a specialty pharmaceutical company utilizing proprietary site-specific nanoparticulate drug delivery systems to develop novel formulations of drugs that are insoluble or poorly soluble in water or have yet to be administrable to the human body with an acceptable delivery method. The Company also discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases and neurodegenerative diseases.
This news release may contain forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. While these statements are meant to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. While management believes such representation to be true and accurate based on the information available to the company, actual results may differ materially from those described. The company's operations and business prospects are always subject to risks and uncertainties. Important facts that may cause actual results to differ are set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
For more information, please click here
168 Konrad Crescent
Suite 200, Markham
Ontario, Canada L3R 9T9
Copyright © PR Newswire Association LLC.
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Treatment of Cell Infection by Nanotechnology September 15th, 2014
Researchers Create World’s Largest DNA Origami September 11th, 2014
Iranian Scientists Discover Nanotechnology Method to Remove Limitations in Tumor Surgery September 11th, 2014
Iranian Nanotechnology Scientists Produce Polymeric Scaffolds for Tissue Engineering September 11th, 2014
‘Small’ transformation yields big changes September 16th, 2014
Fonon at Cutting-Edge of 3D Military Printing: Live-Combat Scenarios Could See a Decisive Advantage with 3D Printing September 15th, 2014
Rice rolls 'neat' nanotube fibers: Rice University researchers' acid-free approach leads to strong conductive carbon threads September 15th, 2014
Simple, Cost-Effective Method Proposed for Synthesizing Zinc Oxide Nanopigments September 15th, 2014
Dolomite to launch Meros TCU-100 temperature controller at Lab-on-a-Chip & Microarray World Congress September 15th, 2014
Seeking Nanoscale Defenses for Biological and Chemical Threats: WPI co-organizes a NATO workshop to improve the detection and decontamination of biological and chemical agents September 13th, 2014
PETA science consortium experts to present at international nanotechology workshop: PETA International Science Consortium, Ltd., Is a Sponsor of Nano Risk Analysis II September 12th, 2014
DELMIC and Phenom-World announce Delphi, the world’s first fully integrated tabletop fluorescence and electron microscope September 8th, 2014